BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28261918)

  • 21. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths).
    Berthelot JM; Maugars Y; Hamidou M; Chiffoleau A; Barrier J; Grolleau JY; Prost A
    Rev Rhum Engl Ed; 1995; 62(7-8):477-86. PubMed ID: 8574610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
    Nakazaki S; Murayama T; Katoh S
    Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
    Bruyn GA; Velthuysen E; Joosten P; Houtman PM
    J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis.
    Pu T; Ni Y; Li PH; Yu D; Yu Q; Yu LM
    Am J Med Sci; 2022 Feb; 363(2):185-190. PubMed ID: 34562416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
    Basin KS; Escalante A; Beardmore TD
    J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
    Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Rheumatol Int; 2020 May; 40(5):765-770. PubMed ID: 32170389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shingles: More than Meets the Eye.
    Komitova RT; Grklanov VA; Lindas KK; Ganeva PV
    Folia Med (Plovdiv); 2019 Mar; 61(1):158-162. PubMed ID: 31237855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate intoxication: Beyond the adverse events.
    Dalkilic E; Coskun BN; Yağız B; Tufan AN; Ermurat S; Pehlivan Y
    Int J Rheum Dis; 2018 Aug; 21(8):1557-1562. PubMed ID: 30146743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics related to methotrexate-induced pancytopenia.
    Ohosone Y; Okano Y; Kameda H; Hama N; Mimori T; Akizuki M; Ikeda Y
    Clin Rheumatol; 1997 May; 16(3):321-3. PubMed ID: 9184276
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pancytopenia in rheumatoid arthritis treated with methotrexate].
    Laroche F; Perrot S; Menkès CJ
    Presse Med; 1996 Sep; 25(25):1144-6. PubMed ID: 8949606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
    Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
    Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis.
    Doolittle GC; Simpson KM; Lindsley HB
    Arch Intern Med; 1989 Jun; 149(6):1430-1. PubMed ID: 2730263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.
    Amissah-Arthur MB; Baah W
    Ghana Med J; 2020 Mar; 54(1):68-71. PubMed ID: 32863415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.
    Mofredj A; Baraka D; Charoud A
    Ann Pharmacother; 2002; 36(7-8):1295. PubMed ID: 12086573
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
    Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N
    Sante; 2006; 16(3):167-72. PubMed ID: 17284392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate induced pancytopenia is rare and concern for it should not limit its use.
    Yazici Y
    Rheumatology (Oxford); 2006 Mar; 45(3):361; author reply 363-4. PubMed ID: 16332954
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors.
    Mameli A; Barcellona D; Marongiu F
    Am J Ther; 2017; 24(1):e106-e107. PubMed ID: 27574942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.